Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia - Kantarjian, HM; Thomas, XG; Dmoszynska, A (J Clin Oncol Off J Am Soc Clin Oncol, 2012)
et al.